Literature DB >> 6096723

Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.

E Müller-Schweinitzer.   

Abstract

Changes in tension were monitored isometrically on spiral strips from human saphenous veins obtained during surgical removal of varicose veins. Concentration-response curves for noradrenaline and 5-hydroxytryptamine (5-HT) were established by cumulative administrations, curves for dihydroergotamine were constructed from the mean responses to single concentrations. The use of the antagonists prazosin, yohimbine and pizotifen provided evidence for the existence of both postjunctional alpha 1- and alpha 2-adrenoceptors and for the existence of 5-HT receptors. The venoconstrictor effects of dihydroergotamine were unchanged by prazosin. Yohimbine antagonized both dihydroergotamine and 5-HT at about 60 times higher concentrations than required against noradrenaline whereas pizotifen inhibited responses to both dihydroergotamine and 5-HT at about 100 times lower concentrations than those to noradrenaline. These new results are in contrast to conclusions drawn from animal studies and do not support the suggestion that in man the venoconstrictor activity of dihydroergotamine is mediated through stimulation of alpha-adrenoceptors. The present results strongly suggest that in human saphenous veins the constrictor activity of dihydroergotamine is mediated at least in part through stimulation of 5-HT receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096723     DOI: 10.1007/bf00506240

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  [Effect of hydrated ergot alkaloids on arterial and venous pressure].

Authors:  D HAMMERSCHMIDT; F ODENTHAL
Journal:  Z Kreislaufforsch       Date:  1950-03

2.  Effects of ergotamine and dihydroergotamine on the resistance and capacitance vessels of skin and skeletal muscle in the cat.

Authors:  E Stürmer
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

3.  Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.

Authors:  O Thulesius; J E Gjöres; E Berlin
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

4.  The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein.

Authors:  P P Humphrey
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

5.  Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation.

Authors:  S Mellander; I Nordenfelt
Journal:  Clin Sci       Date:  1970-08       Impact factor: 6.124

6.  The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective alpha 2-adrenoceptor agonist in vitro.

Authors:  N B Shepperson; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

7.  Dihydroergotamine: pharmacokinetics and usefulness in spinal anaesthesia.

Authors:  H Hilke; J Kanto; R Mäntylä; T Kleimola; E Syvälahti
Journal:  Acta Anaesthesiol Scand       Date:  1978       Impact factor: 2.105

8.  Dual effect of dihydroergotamine and dihydroergotoxin in isolated human femoral veins and arteries.

Authors:  E Glusa; F Markwardt
Journal:  Pharmacology       Date:  1982       Impact factor: 2.547

9.  Characterisation of postjunctional alpha-adrenoceptors in isolated human femoral veins and arteries.

Authors:  E Glusa; F Markwardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

10.  The action of prazosin in human vascular preparations.

Authors:  R A Jauernig; R F Moulds; J Shaw
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-01
View more
  13 in total

1.  Increase of pain threshold by calcitonin during electrical stimulation of the dental pulp. Investigations in healthy volunteers with regard to plasma concentration.

Authors:  K Welzel; D Welzel
Journal:  Schmerz       Date:  1989-09       Impact factor: 1.107

2.  An examination of 5-hydroxytryptamine receptors in human saphenous vein.

Authors:  J R Docherty; L Hyland
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

3.  Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.

Authors:  H Racchi; M J Irarrázabal; M Howard; S Morán; R Zalaquett; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.

Authors:  E Glusa; A Roos
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

5.  Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.

Authors:  C M Villalón; P De Vries; G Rabelo; D Centurión; A Sánchez-López; P Saxena
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.

Authors:  E Müller-Schweinitzer
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

7.  Effects of calcium channel blockers on the contractile response to dihydroergotamine in isolated human femoral veins.

Authors:  E Glusa; F Markwardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

8.  5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins.

Authors:  W A Bax; D Van Heuven-Nolsen; E Bos; M L Simoons; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

9.  Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins.

Authors:  E Glusa; E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

10.  The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.

Authors:  P Schoeffter; C Waeber; J M Palacios; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.